BC-CfE researchers examine aging and comorbidities in people living with HIV

Thanks to the introduction of highly active antiretroviral therapy (HAART) in the 1990s and the BC-CfE’s Treatment as Prevention¨ strategy, people living with HIV (PLWH) in BC are now able to live longer lives. With an increased lifespan, morbidity and mortality from non-AIDS comorbidities have emerged as major concerns.

BC-CfE PhD student Ni Gusti Ayu Nanditha (Ditha), who’s part of the BC-CfE’s EMBARC team (Epidemiological, Mathematical and Biostatistical analysis and Research Collaboration in HIV/AIDS), recognized this issue and recently published a study titled “Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study”.

This population-based cohort study described and compared trends of nine chronic age-related comorbidities among PLWH against a control group. The population-based nature of this study was one of its major strengths, as it included a large number of participants, a 12-year observation span and the ability to seek connections between several provincial healthcare databases. This access enabled an extensive review of individuals’ healthcare use, including physician visits, hospitalizations, and prescription medications.

Through the course of the research, Ditha and her colleagues found PLWH experienced higher prevalence and earlier age at diagnosis of non-AIDS comorbidities than their HIV-negative controls. For instance, we now know PLWH experienced 10 times the burden of liver diseases compared with HIV-negative controls (25.3% vs 2.1%). This was the greatest disparity seen among all chronic diseases. Prevalence of COPD, liver and kidney diseases were found to be substantially elevated among PLWH with a history of injection drug use.

Ditha said, “Overall, this study stresses the need for optimized general clinical screening for chronic diseases at an earlier age among people living with HIV(PLWH). Additionally, our study illustrates a vigorous and replicable methodology that will improve the validity of studies of disease burden, particularly those using administrative health data. In the continuous efforts to address the gaps in care for aging PLWH in BC, our study contributes approaches which address some potential biases that may arise when comparing PLWH to HIV-negative individuals including consideration of differences in the demographics and healthcare engagement level of these populations.”

Share the Post:
Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)